Form 4: DaVita Inc. Executive Exercises Stock Appreciation Rights and Sells Shares
SEC Form 4 Filing
Kathleen Alyce Waters, Chief Legal & Public Affairs Officer at DaVita Inc., exercised stock appreciation rights and sold shares on November 27, 2024.
Summary
- Kathleen Alyce Waters, a Chief Legal & Public Affairs Officer at DaVita Inc., exercised stock appreciation rights on November 27, 2024.
- This transaction involved the acquisition of 8,078 shares of common stock at a price of $108.93 per share.
- Following the exercise, 5,239 shares were sold at $167.96 per share to cover the base price of the stock appreciation rights.
- An additional 1,439 shares were sold at $167.96 per share to satisfy tax withholding obligations.
- After these transactions, Ms. Waters beneficially owns 91,028 shares of DaVita Inc. common stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to executive compensation. It is neither particularly positive nor negative, but rather a standard part of corporate governance.
Industry Context
This is a routine filing related to executive compensation and is common for publicly traded companies. It reflects the standard practice of executives exercising stock-based compensation.
Comparison to Industry Standards
- Stock-based compensation is a common practice across publicly traded companies, particularly in the healthcare sector.
- The vesting schedule of the stock appreciation rights, with 50% vesting after three years and the remainder after four years, is a typical vesting schedule.
- The sale of shares to cover the exercise price and tax obligations is a standard procedure for executives exercising stock options or similar instruments.
- Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also use stock-based compensation as part of their executive pay packages.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves the sale of shares by an executive.
- The transaction is part of the executive's compensation package and does not have a significant impact on the company's operations.
Key Dates
| Date | Description |
|---|---|
| 03/15/2021 | Date the Stock Appreciation Rights were granted. |
| 03/15/2024 | Date 50% of the Stock Appreciation Rights vested. |
| 11/27/2024 | Date of the stock appreciation rights exercise and share sales. |
| 03/15/2025 | Date the remaining 50% of the Stock Appreciation Rights will vest. |
| 03/15/2026 | Expiration date of the Stock Appreciation Rights. |
Keywords
Stock Appreciation Rights, Form 4, Insider Trading, DaVita Inc., DVA, Executive Compensation, Share Transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.